NASDAQ · CODX
Co-Diagnostics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CODX: Nov 12, 2026
Co-Diagnostics, Inc. Common Stock is expected to report earnings on 11/12/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-4.8.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · MarketBeat- RTTNews · Oct 8, 12:54 PM EDTCo-Diagnostics Expands Vector Smart With First Tribal Laboratory Installation(RTTNews) – Co-Diagnostics (CODX) has received an order from the Ute Indian Tribe Mosquito Abatement Department for a complete Vector Smart mosquito surveillance laboratory installation, marking the company's first full installation for a Native American tribe.
- RTTNews · Sep 16, 9:46 AM EDTCo-Diagnostics, ReadyGo Advance Blood-Based Ebola Testing At The Point Of Need; Stock Down(RTTNews) – Co-Diagnostics Inc. (CODX), a molecular diagnostics company developing patented PCR-based testing technology, has entered a collaboration with ReadyGo Diagnostics Ltd. to evaluate blood-based molecular testing using the Co-Dx PCR platform, beginning with decentralized
- The Motley Fool · Aug 20, 7:50 PM EDTCo-Dx (CODX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Jun 2, 11:05 AM EDTCo-Diagnostics And CoSara Advance Development Of Ebola PCR Test And Point-of-Care Platform; Stock Up(RTTNews) – Co-Diagnostics Inc. (CODX) and its joint venture CoSara Diagnostics Pvt. Ltd. announced progress in developing a PCR-based diagnostic test for Ebola virus, alongside enhancements to the Co-Dx PCR point-of-care platform.
- RTTNews · May 29, 2:27 AM EDTTop Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest(RTTNews) – In Thursday's list of gainers, we highlight SciSparc, which received the regulatory go-ahead to acquire a stake in a private Israeli technology company, Co-Diagnostics, which extended its rally for the third straight day, and Tevogen, which is making continued progres
- MarketBeat · May 28, 11:00 AM EDTIs Co-Diagnostics National Security’s Next Diagnostic Pick?A structural shift is underway in the biodefense landscape. The declaration of a Public Health Emergency of International Concern (PHEIC) by the World Health Organization on May 17, 2026, for the Bundibugyo virus Ebola outbreak should be seen by investors as more than a headline
- RTTNews · May 28, 8:43 AM EDTPre Market Movers: WGRX, CODX, AIM Set The Pace(RTTNews) – Biotech companies are seeing significant pre-market activity this Thursday, hinting at possible breakout opportunities.
- The Motley Fool · May 27, 4:52 PM EDTCo-Diagnostics (CODX) Q4 2025 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · May 27, 3:54 AM EDTTop Biotech Gainers: CODX Soars On Ebola Assay Progress, NRXP Nears FDA Decision, NVAX On Watch(RTTNews) – Today's Top Gainers list includes CODX, which is advancing the development of its Ebola PCR Assay; NRXP, which has a couple of near-term regulatory catalysts to watch; ECOR, whose latest SEC filing reveals an insider transaction; and OTLK, which reported an encouragin
- RTTNews · May 26, 1:19 PM EDTCo-Diagnostics Advances Ebola PCR Assay Strategy With CoSara; Shares Surge(RTTNews) – Co-Diagnostics Inc. (CODX), a molecular diagnostics company, announced it has advanced development of a PCR assay for Bundibugyo virus (BDBV), the strain currently driving an Ebola outbreak in the Democratic Republic of the Congo and Uganda. The program is being suppo
- RTTNews · May 22, 10:47 AM EDTWeekly Buzz: GH Wins FDA Nod; NMPA Green Lights HCM; MDT To Acquire SPR ; BIIB HALTS BIIB112(RTTNews) – This week's biotech landscape saw regulatory approvals across the U.S., Canada, and China, alongside collaborations, acquisitions, program halts, and positive data readouts spanning multiple therapeutic areas, including severely calcified coronary artery disease, Wils
- RTTNews · May 21, 10:34 PM EDTBiotech Stock Gainers: CODX Extends Rally, SBFM Surges, GOVX Ebola Strategy, RGNX Awaits Catalysts(RTTNews) – Today's gainers include CODX, which rallied for the third straight day; Akari, on breakthrough clinical data in pancreatic cancer; Sunshine, following regulatory approval for its generic Amoxicillin; GOVX, amid Ebola concerns; and RGNX, on upcoming clinical trial mile
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Co-Diagnostics, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.